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T cells serve as key weapons in the 
mammalian immune system’s arsenal, 
defending the host against invading 
pathogens such as bacteria and viruses. 
But sometimes these powerful weapons 
attack host tissues, wreaking havoc 
in the form of autoimmune diseases 
like lupus erythematosus and multiple 
sclerosis. The immune system uses 
two main mechanisms to prevent such 
attacks: negative selection, in which 
T cells with a high affinity for host 
peptides are sentenced to death before 
they leave the thymus (where T cells 
develop), and dominant tolerance, in 
which a specialized subpopulation of 
T cells modulate the activity of T cells 
and other lymphocytes against host 
tissue and pathogens. These regulatory 
T (Treg) cells, which help prevent 
autoimmune disease by dampening 
immune responses, are characterized by 
expression of the Foxp3 transcription 
factor and are mostly derived from 
the thymus. However, recent research 
indicates that a small percentage of 
CD4+Foxp3+ Treg cells may develop not 
in the thymus, but in the peripheral 
lymphoid organs (lymph nodes and 
spleen). Although it’s possible that Treg
cells produced in either the thymus 
or the periphery perform different 
tasks, the two populations appear 
indistinguishable in wild-type mice.
To find out what might set 
peripheral Treg cells apart from their 
thymic counterparts, Michael Barnes 
and colleagues induced genetic 
mutations in mice using the chemical 
N-ethyl-N-nitrosourea (ENU). By 
screening for mice with defects in T 
cell development and function, the 
researchers identified a mutation 
in a gene called Carma1 (which was 
previously shown to play a key role in 
T and B cell signaling) that caused 
mice to have essentially no thymic Treg
cells. However, they did have a small 
population of Treg cells in their spleen, 
lymph nodes, and colon, indicating 
that Treg cells might still be developing 
in the peripheral lymphoid organs. In 
vitro, these peripheral Treg cells could 
be induced to express Foxp3 and 
proliferate in response to the cytokines 
TGFB and IL-2, which are produced at 
increased levels during infection.
Unlike most mice with mutations 
that impair Treg cell development, the 
Carma1-mutant mice did not exhibit 
any obvious signs of autoimmune 
disease, such as an enlarged spleen 
or chronic inflammation. This 
indicates that although Treg cells were 
not being produced in the thymus, 
dominant tolerance was not entirely 
absent because of the presence of 
the peripheral Treg cells. To see if the 
Treg cells observed in the periphery of 
Carma1-mutant mice were capable of 
expanding in response to pathogens, 
the researchers infected the mice with 
mouse cytomegalovirus (MCMV). 
Although Foxp3 expression and 
massive Treg expansion were observed 
in the periphery 14 days after infection, 
no Foxp3+ cells were detected in the 
thymus, indicating that the expanded 
Tregcells arose from the small pool of 
peripheral Tregcells.
Why might there be distinct thymic/
Carma1-dependent and peripheral/
Carma1-independent pathways for 
inducing Foxp3 expression and thus 
committing CD4+ cells to the Treg cell 
lineage? By having a pool of Treg cells 
with two potential fates, the immune 
system gains flexibility in how it 
induces and modulates its responses. 
Thus, while under normal conditions, 
thymic Treg cells might be automatically 
generated and proliferate to compose 
the majority of the Treg pool, the 
generation and massive expansion of 
peripheral Treg cells could be quickly 
induced by cytokines produced in 
response to invasion by pathogens. 
During an immune response, the 
Carma1-independent pathway could 
allow some T cells to become Treg
cells and expand rapidly, which could 
protect the host from cross-reactive 
antipathogen T cells that might 
otherwise attack self tissue and cause 
autoimmune disease. For example, 
impaired immune regulation often 
leads to the autoimmune disease 
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CARMA1 (purple oval), part of a signaling pathway required for regulatory T cell 
development in the thymus, links T cell receptor ligation to activation of the transcription 
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colitis. That elevated numbers of 
Treg cells normally reside in the 
colon and can expand even in the 
absence of Carma1 suggests that the 
Carma1-independent pathway may be 
important for regulating responses 
to the billions of bacteria that reside 
in the intestines of healthy mice. On 
the flipside, however, suppressing 
the immune response could lead 
to chronic infection, particularly if 
Treg cells are localized to pathogen 
reservoir sites. Indeed, previous 
research has shown that some 
pathogens can manipulate the host 
immune response to their advantage 
by promoting the expansion of the Treg
cells that prevent their eradication by 
the immune system. By learning more 
about how Treg cells are generated and 
their role in the immune response, 
researchers might one day be able to 
manipulate them therapeutically by 
suppressing their function to fight 
infection or by enhancing it  to prevent 
autoimmune disease.
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